RE: Gift wrapped part of lucrative chain18 Mar 2021 08:23
Good morning everyone!
IF a TO is coming it would most likely come after the POC assay is launched and Beckman have confirmed clients for our bead test. Just my opinion after looking into Danaher Corporation Strategy and where David has positioned Genedrive between Cytiva and Beckman. From a sales growth outlook we are only just starting to sell with Beckman so I anticipate that to steadily grow. We also have other revenue streams starting soon with POC covid assay, Hearing loss assay and not forgetting the Mountain Horse distribution agreement for our pathogen detection kit. I don’t make outlandish price predictions, I just know a company that has loads of potential and will be worth a lot more than it currently is today once we launch all our products.